Viewing StudyNCT00096707



Ignite Creation Date: 2024-05-05 @ 11:38 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00096707
Status: COMPLETED
Last Update Posted: 2009-04-29
First Post: 2004-11-12

Brief Title: Dose Escalation Trial of 2-Deoxy-D-Glucose 2DG in Subjects With Advanced Solid Tumors
Sponsor: Threshold Pharmaceuticals
Organization: Threshold Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Gastric Cancer
Lung Cancer
Breast Cancer
Pancreatic Cancer
Head and Neck Cancer
Keywords:
Name View
advanced solid tumors View
cancer View
docetaxel View
2-deoxy-D-glucose 2DG View
phase 1 View